Aurinia Pharmaceuticals
AUPH
$5.10
Share price
-1.35%
Change (1 day)
-55.96%
Change (1 year)
Categories
Aurinia Pharmaceuticals (AUPH) - P/B ratio
P/B ratio as of May 2024 : 1.96
According to Aurinia Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 1.96.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Aurinia Pharmaceuticals - P/B ratio (from 2009 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 3.42 | 125.59% |
| 2022-12-31 | 1.51 | -75.54% |
| 2021-12-31 | 6.19 | 44.81% |
| 2020-12-31 | 4.27 | -43.27% |
| 2019-12-31 | 7.54 | 45.62% |
| 2018-12-31 | 5.17 | 124.19% |
| 2017-12-31 | 2.31 | -0.49% |
| 2016-12-31 | 2.32 | -42.81% |
| 2015-12-31 | 4.06 | 20.78% |
| 2014-12-31 | 3.36 | -1.87% |
| 2013-12-31 | 3.42 | -167.97% |
| 2012-12-31 | -5.03 | -257.89% |
| 2011-12-31 | 3.19 | -50.1% |
| 2010-12-31 | 6.39 | 48.51% |
| 2009-12-31 | 4.30 | |
| 2008-12-31 | N/A | |
| 2007-12-31 | N/A | |
| 2006-12-31 | N/A | |
| 2005-12-31 | N/A | |
| 2004-12-31 | N/A | |
| 2003-12-31 | N/A | |
| 2002-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | 3.98 | 103.32% | 🇺🇸 USA |
 Pieris Pharmaceuticals PIRS | 0.4556 | -76.71% | 🇺🇸 USA |
 Aeterna Zentaris AEZS | 0.5364 | -72.58% | 🇺🇸 USA |